Cavotec MSL Holdings Limited said that an $18m secondary share placement to institutional and other habitual investors was executed on April 19.
The placement was sole lead managed and underwritten by the investment banking firm Goldman Sachs JBWere.
Thirteen current shareholders of Cavotec MSL participated in the transaction, including certain managers, directors and founding shareholders of the company. On average, these shareholders sold approximately 5% of their holdings. Each selling manager shareholder is
subject to a standstill on further sales for a minimum period of 6 months.